MENS
MENS
NASDAQ · Biotechnology

Jyong Biotech Ltd

$1.87
+0.21 (+12.65%)
As of Feb 8, 2:08 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 66.78M 62.47M 71.10M
Net Income 5.53M 4.95M 5.20M
EPS
Profit Margin 8.3% 7.9% 7.3%
Rev Growth +15.6% -3.5% +12.7%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 18.44M 16.43M 20.60M
Total Equity 79.46M 76.73M 77.77M
D/E Ratio 0.23 0.21 0.26
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 7.58M 8.61M 8.78M
Free Cash Flow 4.38M 4.03M 6.15M